JPRN-UMIN000008010
Completed
未知
Clinical study to evaluate anti-inflammatory effects of intravenous azithromycin add-on therapy for the treatment of bacterial pneumonia. - Clinical study to evaluate anti-inflammatory effects of intravenous azithromycin add-on therapy (YCRG0008)
ConditionsPneumonia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Pneumonia
- Sponsor
- Yokohama City University Medical Center
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Patients with hypersensitivity to azithromycin, macrolide or ketolide antibiotic agents (2\) Patients with hypersensitivity to levofloxacin or ofloxacin (3\) Patients with liver dysfunction (AST, ALT, and total bilirubin \> 3 times upper limit of normal range) (4\) Patients with severe renal dysfunction (creatinine clearance \<30 mL/min) (5\) Patients with prior or current evidence of severe heart diseases (NYHA grade IV), congenital or sporadic prolongation of the QT interval, or receiving medications known to cause prolongation of the QT interval (6\) Patients with severe underlying diseases or complications that have the difficulties of the evaluations of drug efficacy (7\) Patients who require other systemic antibiotic treatments (8\)Patients by whom other antimicrobial drugs (internal use or injection) were prescribed for the patient exceeding 48 hours to this infection before investigational new drug trial drug medication (9\)Patients with gastrointestinal disorders disrupting drug absorption (10\)Pregnant women or females with childbearing potential (11\) Any other condition which, in the opinion of the investigator, would make the subject unsuitable for enrollment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study concerning anti-inflammatory effect of fixed dose therapy by budesonide/formoterol combination inhaler for moderate persistent asthmatics.Bronchial asthmaJPRN-UMIN000011853ational Center for Global Health and Medicine50
Not yet recruiting
Not Applicable
Clinical Study to Evaluate the Anti-Inflammatory and Beneficial Effects ofBeta Glucan food supplement on Duchenne muscular dystrophy (DMD) PatientsCTRI/2022/05/042905MediNippon Health Care Private Limited MD
Not yet recruiting
Not Applicable
Clinical Study to Evaluate the Anti-Inflammatory and Beneficial Effects ofBeta Glucan foodsupplement on another Muscular Dystrophy other than DMD PatientsCTRI/2022/05/042917MediNippon Health Care Private Limited MD
Recruiting
Phase 3
A study on therapeutic and anti-inflammatory effects of probiotic in asthmatic patients referred to kowsar semnan hospitalAsthmatic.Mild intermittent asthma with status asthmaticusJ45.22IRCT20151228025732N54Semnan University of Medical Sciences60
Completed
Phase 1
Evaluation of efficacy and anti-inflammatory action of PlacentrexTM in women with inflammatory Pap smears.CTRI/2010/091/000197ALBERT DAVID LTD KOLKATA150